摘要:
Preventives and/or remedies for liver diseases containing as the active ingredient monocyte chemoattractant protein-1 (MCP-1) function inhibitors. Administration of the MCP-1 function inhibitors exerts effects of preventing and/or treating liver diseases.
摘要:
Granular medicinal compositions containing a drug having an offensive taste, a waxy substance and a sugar alcohol; a process for producing the same and oral medicinal preparations containing these compositions. Because of having an excellent effect of masking the offensive taste of the drug and a good feel in using, these preparations can be easily taken by aged persons, children and patients with difficulty in swallowing. These preparations are suitable for tube administration too.
摘要:
A novel mechanical stimulus-responsive channel protein originating in mouse or humans which is expressed specifically in the kidney and has a function of non-selectively incorporating cation into cells respondent to a mechanical stimulus; a DNA encoding this protein; a method of screening a cation channel activity enhancer or inhibitor with the use of this protein; and an antibody against this protein. The above-described protein is useful as a diagnostic or a remedy for diseases based on abnormalities in the cation channel such as hypertension or diabetes or as a tool for searching for preventives and/or remedies for these diseases.
摘要:
A method for assaying a DDS compound containing a saccharide compound-modified carboxy C1-4 alkyldextran polyalcohol and a drug compound residue bonded to this carboxy C1-4 alkyldextran polyalcohol, or a DDS compound wherein a polymer carrier is bonded to a drug compound residue via a spacer containing 2 to 8 amino acids bonded together via peptide bonds, which involves the step of assaying a hydrolysate obtained by treating the DDS compound with peptidase.
摘要:
Novel preventives and/or remedies for sepsis. The above preventives and/or remedies contain as the active ingredient tumor cytotoxic factor-II (TCF-II) and exert particularly excellent effects on sepsis caused by at least one factor selected from the group consisting of infectious disease, burn, operation, cancer, acquired immunological deficiency syndrome (AIDS), radiation therapy, chemotherapy and total parenteral nutrition (TPN).
摘要:
Processes for preparing intermediate compounds (VII) and compounds (VIII) and (XIV), which are useful as raw materials in the synthesis of antimicrobial compounds, from compounds (I) or (X) trough compounds (II); and novel compounds useful in the processes.
摘要:
Novel Taxol derivatives having various substituents as represented by general formula (I) and being usable as antitumor compounds which can be orally administered.
摘要:
A process for preparing compounds represented by general formulae (5) and (6) in the following reaction scheme or salts thereof, wherein R1 represents a nitrogen protective group; R2 represents a methanesulfonyl or p-toluenesulfonyl group; R3 represents a hydrogen atom, an aralkyl group, or an alkyl group having 1 to 6 carbon atoms, and X represents a halogen atom. The above process is useful as a commercial process for preparing intermediates of anticoagulant aromatic amidine derivatives described in Japanese Patent Laid-Open No. 208946/1993.
摘要:
A pharmaceutical which is useful for prevention and/or treatment of amnesia attributable to an intravenously administrable anaesthetic, for example, propofol, and contains as the active ingredient a compound represented by the general formula: R -CH2CONH-R (wherein R represents a pyridyl group, a substituted pyridyl group, a phenyl group, or a substituted phenyl group; and R represents an optionally substituted 2-oxo-1-pyrrolidinyl group), for example, N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide.
摘要:
Novel dry skin remedies useful for the treatment of dry skin, containing as the active ingredient spiro[oxathiolane-quinuclidine] derivatives represented by general formula (I) or acid addition salts thereof, desirably cis-2-methylspiro[1,3-oxathiolane-5,3'-quinuclidine] hydrochloride. The remedies promote the secretion of sebaceous and sweat glands through oral or parenteral administration to treat dry skin, thus being useful as drugs.